Home Economic evidence in decision-making process in laboratory medicine
Article
Licensed
Unlicensed Requires Authentication

Economic evidence in decision-making process in laboratory medicine

  • Massimo Brunetti , Silvia Pregno , Holger Schünemann , Mario Plebani and Tommaso Trenti EMAIL logo
Published/Copyright: March 11, 2011

Abstract

Laboratory data play a pivotal role in the clinical decision-making process. Major transformations have occurred in laboratory medicine in recent decades. To face the economic pressures, hospital laboratories are forced to enhance efficiency. Decisions on policy and practice take place at many levels. However, decision-making often does not follow Evidence Based Laboratory Medicine principles. Also, the literature shows limited influence of economic evaluations on health care decisions and diagnostic processes. Several barriers to the use of economic evaluation in decision-making process have been identified, and guidelines tend to focus on issues of effectiveness and have not explicitly considered broader issues, particularly cost. As an example, we analyzed recommendations on the use of brain natriuretic peptide (BNP) or N-terminal fragment of the prohormone BNP (NT-proBNP) in patients with chronic heart failure. All guidelines recommend the use of BNP if available. Nevertheless, none included economic data explicitly, even if economic information exists in the literature. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group, propose using a balance sheet approach, one way of helping decision makers to explicitly consider resource use along with other outcomes when making recommendations. Key aspects of GRADE, such as the explicit presentation of information and the quality evaluation of the economic data can help overcome barriers in the use of economic evaluations in the decision-making in process. This approach can help to give health decision makers, clinical guideline panels and patients, a better appreciation of the overall health benefits, harms and costs of laboratory tests.


Corresponding author: Tommaso Trenti, Patologia Clinica, Tossicologia e Diagnostica Avanzata, Nuovo Ospedale S. Agostino Estense, via Giardini 1355, Modena, Italy Phone: +390593961467, Fax: +390593961249

Received: 2010-11-6
Accepted: 2010-12-17
Published Online: 2011-03-11
Published in Print: 2011-04-01

©2011 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. Nuclear and radiation accidents: the next and further challenge for laboratory diagnostics
  3. Reviews
  4. Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases
  5. Miniaturization and globalization of clinical laboratory activities
  6. Inflammatory markers in childhood asthma
  7. Age-related macular degeneration: genetic and clinical findings
  8. Opinion Paper
  9. Economic evidence in decision-making process in laboratory medicine
  10. Point
  11. A new concept to derive permissible limits for analytical imprecision and bias considering diagnostic requirements and technical state-of-the-art
  12. Counterpoint
  13. Do new concepts for deriving permissible limits for analytical imprecision and bias have any advantages over existing consensus?
  14. Genetics and Molecular Diagnostics
  15. Non-invasive prenatal diagnosis of trisomy 21 by reverse transcriptase multiplex ligation-dependent probe amplification
  16. General Clinical Chemistry and Laboratory Medicine
  17. Evaluation of the Menarini/ARKRAY ADAMS A1c HA-8180V analyser for HbA1c
  18. Evaluation of two HbA1c point-of-care analyzers
  19. Indirect reference intervals of plasma and serum thyrotropin (TSH) concentrations from intra-laboratory data bases from several German and Italian medical centres
  20. Pseudohypocalcemia caused by perchlorate (Irenat®)
  21. Serum cholesterol measured by isotope dilution liquid chromatography tandem mass spectrometry
  22. Confirmation of congenital adrenal hyperplasia by adrenal steroid profiling of filter paper dried blood samples using ultra-performance liquid chromatography-tandem mass spectrometry
  23. Sensitivity and specificity of the high fluorescent lymphocyte count-gate on the Sysmex XE-5000 hematology analyzer for detection of peripheral plasma cells
  24. Clauss assay and fibrinogen protein estimated by capillary zone electrophoresis
  25. High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practice
  26. Cancer Diagnostics
  27. Detection of HOXA9 gene methylation in tumor tissues and induced sputum samples from primary lung cancer patients
  28. MMP-9 expression in peripheral blood mononuclear cells and the association with clinicopathological features and prognosis of nasopharyngeal carcinoma
  29. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma
  30. Cardiovascular Diseases
  31. B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent’s Screening TO Prevent Heart Failure) study
  32. Elevated concentrations of Nɛ-homocysteinyl-lysine isopeptide in acute myocardial infarction: links with ADMA formation
  33. Letters to the Editor
  34. More on preanalytical variables affecting platelet function testing using light transmittance aggregometry
  35. Relationship of hepatic steatosis and alanine aminotransferase with coronary calcification
  36. Why do different EQA schemes have apparently different limits of acceptability?
  37. Prevalence of antithyroid antibodies and thyroid-stimulating hormone concentration in young people
  38. Evaluation of multiplex PCR using dual-priming oligonucleotide for the detection of vanA and vanB in vancomycin-resistant enterococci
  39. The IFCC Task Force for Young Scientists
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2011.119/pdf
Scroll to top button